Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies.
about
Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein AssembliesDrug modulation of water-heme interactions in low-spin P450 complexes of CYP2C9d and CYP125A1.Hole hopping through tyrosine/tryptophan chains protects proteins from oxidative damage.Evidence That Compound I Is the Active Species in Both the Hydroxylase and Lyase Steps by Which P450scc Converts Cholesterol to Pregnenolone: EPR/ENDOR/Cryoreduction/Annealing StudiesComparison of the Mechanisms of Heme Hydroxylation by Heme Oxygenases-1 and -2: Kinetic and Cryoreduction StudiesSpectroscopic and Crystallographic Evidence for the Role of a Water-Containing H-Bond Network in Oxidase Activity of an Engineered Myoglobin.Isotope-Labeling Studies Support the Electrophilic Compound I Iron Active Species, FeO(3+), for the Carbon-Carbon Bond Cleavage Reaction of the Cholesterol Side-Chain Cleavage Enzyme, Cytochrome P450 11A1Nanodiscs in Membrane Biochemistry and Biophysics.Spectroscopic studies of the cytochrome P450 reaction mechanisms.Electron paramagnetic resonance and electron-nuclear double resonance studies of the reactions of cryogenerated hydroperoxoferric-hemoprotein intermediates.Origin of the Regioselective Fatty-Acid Hydroxylation versus Decarboxylation by a Cytochrome P450 Peroxygenase: What Drives the Reaction to Biofuel Production?Exchangeable proton ENDOR as a probe of the redox-active iron center in activated bleomycin and ferric bleomycin.
P2860
Q26741511-41BA48B2-3CAF-4D63-A489-73B877080C51Q35624528-23754F67-B868-40CC-91BA-EA5A862FF4E9Q36055452-A778EF8C-A169-4E65-9B91-B9C18B6FFC08Q36519325-8299BDE8-E661-4A64-BAE8-D0BB71503278Q36557800-2D8978E8-CF52-47D4-B922-11312FF3CE45Q36571170-8FAA42F6-A7E2-4F2D-8EC2-21D0D69EC3B5Q37621940-675AC257-8B94-4251-B03D-3665F7C7EB18Q39126044-BDA70A39-8D4C-466B-9DA3-1AF485445EAFQ39409036-52DA0109-5338-4CFC-8CD0-56795EC33339Q42154931-31C3D48D-06E4-4683-84F0-C562BFB895B1Q51491253-C4FA7110-F0C9-427E-AA40-6DD24E736625Q52574170-892FB43D-C395-48CB-BD2D-B9E96D27D323
P2860
Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Compound I is the reactive int ...... yoreduction/annealing studies.
@ast
Compound I is the reactive int ...... yoreduction/annealing studies.
@en
type
label
Compound I is the reactive int ...... yoreduction/annealing studies.
@ast
Compound I is the reactive int ...... yoreduction/annealing studies.
@en
prefLabel
Compound I is the reactive int ...... yoreduction/annealing studies.
@ast
Compound I is the reactive int ...... yoreduction/annealing studies.
@en
P2093
P2860
P356
P1476
Compound I is the reactive int ...... yoreduction/annealing studies.
@en
P2093
Andrey A Gilep
Brian M Hoffman
Natallia V Strushkevich
Roman Davydov
Sergey A Usanov
P2860
P304
17149-17156
P356
10.1021/JA3067226
P407
P577
2012-10-05T00:00:00Z